Financhill
Back

Vertex Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Sell
49

VRTX
Vertex Pharmaceuticals

Last Price:
$411.98
Seasonality Move:
0.36%
Sell
23

NUKK
Nukkleus

Last Price:
$21.01
Seasonality Move:
48.46%
Sell
49
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $412.11. The Score for VRTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $21.00. The Score for NUKK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $412.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $21.00
    The current trend is moderately bearish and NUKK is experiencing slight selling pressure.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.17 Sell
Relative Strength Index (14 RSI): 39.66 Sell
Chaikin Money Flow: 1039510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (403.26 - 463.28) Sell
Bollinger Bands (100): (438.3 - 490.76) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.09 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: -90986 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 39.18) Sell
Bollinger Bands (100): (-5.25 - 19.13) Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 405.83 Buy
20-day SMA: 425.74 Sell
50-day SMA: 454.35 Sell
200-day SMA: 456.89 Sell
8-day EMA: 409.06 Buy
20-day EMA: 422.04 Sell
50-day EMA: 443.51 Sell
200-day EMA: 448.45 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30 Sell
20-day SMA: 26.02 Sell
50-day SMA: 11.64 Buy
200-day SMA: 6.16 Buy
8-day EMA: 27.7 Sell
20-day EMA: 25.09 Sell
50-day EMA: 16.11 Buy
200-day EMA: 13.92 Buy

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.19 per share, and an increase next year of $2.07 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):